Jazz Pharmaceuticals (JAZZ) Broke Out To Nearly A 4-Month High

Jazz Pharmaceuticals (JAZZ) announced after the bell Tuesday that the first patient has been enrolled in its Phase 3 clinical trial of defibrotide.

from RTT - Before the Bell http://ift.tt/2iNh1el
via IFTTT